Study offers understanding into metabolic pathways hijacked by SARS-CoV-2 for viral replication Kumar Jeetendra | March 16, 2021 When SARS-CoV-2, the virus which causes COVID-19, infects a human cell, it quickly begins to replicate by seizing the cell’s existing metabolic machinery. The infected cells churn out thousands of viral genomes and proteins while halting the creation of their own sources. Researchers from Brigham and Women’s Hospital, Massachusetts General Hospital (MGH), and the Broad …
Sweden stops AstraZeneca COVID-19 vaccinations Kumar Jeetendra | March 16, 2021 Sweden’s health agency said on Tuesday it was pausing vaccinations from COVID-19 using AstraZeneca’s vaccine as a preventative measure. Germany, France and Italy said on Monday they would stop administering the AstraZeneca COVID-19 vaccine after several countries reported possible serious side-effects while the World Health Organization has said there was no proven link. “The Swedish …
AstraZeneca to supply 500,000 more COVID-19 vaccine mixed drink to US Kumar Jeetendra | March 16, 2021 AstraZeneca Pharma India | The Organization has Obtained import and market Consent in form CT-20 (Following new drug approval) from the Drugs Controller General of India for Osimertinib 40mg/80mg film coated tablets (TagrissoTM). The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets into a new disease area in …
Killing antibodies actuated by COVID-19 vaccines less successful against new variants Kumar Jeetendra | March 15, 2021 SARS-CoV-2, the virus that causes COVID-19, has mutated through the pandemic. New variants of this virus have arisen around the world, including variants that might possess increased capacity to spread or evade the immune system. Such variations have been identified in California, Denmark, the U.K., South Africa and Brazil/Japan. Recognizing how well the COVID-19 vaccines …
Ordinary promoter vaccines are the future fighting with COVID-19 infection, top genome experts says Kumar Jeetendra | March 15, 2021 Standard booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain’s attempt to sequence the virus’s genomes told Reuters. The novel coronavirus, which has killed 2.65 million individuals globally since it emerged in China in late 2019, …
Italy plans to immunize atleast 80% of populace by end of September Kumar Jeetendra | March 14, 2021 Italy said on Saturday it aimed to vaccinate at least 80 percent of its population at the end of September, after criticism about the slow pace of the rollout of a coronavirus vaccination campaign in one of worst-hit countries in Europe. Francesco Paolo Figliuolo, a military general and new special commissioner for coronavirus, published a …
AstraZeneca to look for US approval for COVID-19 vaccine this month or early next: Sources Kumar Jeetendra | March 13, 2021 The British drugmaker completed enrollment in its trial of more than 32,000 volunteers in January and now has data on at least 150 cases of COVID-19, two sources knowledgeable about the trial told Reuters. The amount of COVID-19 cases among those who got the vaccine versus infections in participants who received a placebo will show …
Novel device can add or eliminate sugar from proteins Kumar Jeetendra | March 12, 2021 Sugar has been called “evil,” “toxic,” and “poison.” But the body needs sugars, also. Sugar molecules help cells recognize and fight germs and viruses, shuttle proteins from cell to cell, and make sure those proteins function. Too much or too small can give rise to a range of maladies, including neurodegenerative diseases like Alzheimer’s, diabetes, …
No reason to quit utilizing AstraZeneca COVID-19 immunization, says WHO Kumar Jeetendra | March 12, 2021 The World Health Organization said Friday there was no reason to stop using AstraZeneca’s COVID-19 vaccine following several European nations suspended the roll-out over blood clot fears. The WHO said its vaccines advisory committee was now looking at safety data and worried that no causal connection was established between the vaccine and clotting. Denmark, Norway, …
Mosquito protein study could prompt therapeutics against dangerous viruses Kumar Jeetendra | March 11, 2021 The researchers found that AEG12 works by destabilizing the viral envelope, breaking its protective covering. Although the protein doesn’t affect viruses that don’t have an envelope, such as the ones that cause pink eye and bladder ailments, the findings could lead to therapeutics against viruses which affect millions of people around the world. The research …
Denmark suspends utilization of AstraZeneca antibody over over blood clot fears Kumar Jeetendra | March 11, 2021 Danish health authorities said Thursday they were temporarily suspending the use of AstraZeneca’s Covid-19 vaccine after some patients developed blood clots because receiving the jab. The move comes”following reports of serious cases of blood clots among individuals vaccinated with AstraZeneca’s Covid-19 vaccine”, the Danish Health Authority said in a statement. But it carefully added that”it …
Huron Digital Pathology TissueScope iQ Scanner recieved CE-IVD Mark Kumar Jeetendra | March 10, 2021 Huron Digital Pathology has received a CE-IVD mark for its high throughput TissueScope iQ 400 slide whole slide scanner. The CE mark indicates that the TissueScope iQ scanner complies with the European In Vitro Diagnostic Regulations. With this certification, Huron accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally …
